Eli Lilly & Co. (LLY)
1169.60
-19.12
(-1.61%)
USD |
NYSE |
Oct 08, 16:00
1169.24
-0.36
(-0.03%)
Pre-Market: 08:52
Eli Lilly 30-Day Average Daily Volume : 2.348M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 2.348M |
| October 07, 2026 | 2.345M |
| October 06, 2026 | 2.339M |
| October 05, 2026 | 2.324M |
| October 02, 2026 | 2.341M |
| October 01, 2026 | 2.360M |
| September 30, 2026 | 2.439M |
| September 29, 2026 | 2.409M |
| September 28, 2026 | 2.414M |
| September 25, 2026 | 2.424M |
| September 24, 2026 | 2.424M |
| September 23, 2026 | 2.408M |
| September 22, 2026 | 2.407M |
| September 21, 2026 | 2.425M |
| September 18, 2026 | 2.439M |
| September 17, 2026 | 2.402M |
| September 16, 2026 | 2.553M |
| September 15, 2026 | 2.641M |
| September 14, 2026 | 2.676M |
| September 11, 2026 | 2.701M |
| September 10, 2026 | 2.740M |
| September 09, 2026 | 2.746M |
| September 08, 2026 | 2.757M |
| September 04, 2026 | 2.730M |
| September 03, 2026 | 2.723M |
| Date | Value |
|---|---|
| September 02, 2026 | 2.701M |
| September 01, 2026 | 2.671M |
| August 31, 2026 | 2.657M |
| August 28, 2026 | 2.643M |
| August 27, 2026 | 2.653M |
| August 26, 2026 | 2.655M |
| August 25, 2026 | 2.640M |
| August 24, 2026 | 2.657M |
| August 21, 2026 | 2.670M |
| August 20, 2026 | 2.654M |
| August 19, 2026 | 2.636M |
| August 18, 2026 | 2.572M |
| August 17, 2026 | 2.586M |
| August 14, 2026 | 2.604M |
| August 13, 2026 | 2.638M |
| August 12, 2026 | 2.665M |
| August 11, 2026 | 2.724M |
| August 10, 2026 | 2.776M |
| August 07, 2026 | 2.933M |
| August 06, 2026 | 2.929M |
| August 05, 2026 | 2.912M |
| August 04, 2026 | 2.807M |
| August 03, 2026 | 2.771M |
| July 31, 2026 | 2.823M |
| July 30, 2026 | 2.806M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Johnson & Johnson | 6.661M |
| Merck & Co., Inc. | 9.401M |
| Pfizer Inc. | 33.11M |
| Bristol Myers Squibb Co. | 11.23M |
| Structure Therapeutics, Inc. | 1.366M |